Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: Assessment of its usefulness in workers exposed to styrene

International Archives of Occupational and Environmental Health

Volumn 75, Issue 7, 2002, Pages 453-458

  Haufroid, Vincent ^a   Buchet, Jean Pierre ^a   Gardinal, Sophie ^a   Lison, Dominique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Biological monitoring; Chlorzoxazone; Cytochrome P4502E1; Phenotype; Styrene

Indexed keywords

CHLORZOXAZONE; CYTOCHROME P450 2D1; CYTOCHROME P450 2E1; DRUG METABOLITE; GLASS FIBER; STYRENE;

ADULT; ALLELE; ARTICLE; BIOLOGICAL MONITORING; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG METABOLISM; ENVIRONMENTAL MONITORING; ENZYME ACTIVITY; FUNCTIONAL ASSESSMENT; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; METABOLIC RATE; METABOLITE; MUTANT; OCCUPATIONAL EXPOSURE; PHENOTYPE; PLASTIC INDUSTRY; POPULATION RESEARCH; SHIFT WORKER; TABLET; URINALYSIS; URINARY EXCRETION; WILD TYPE;

ADULT; BELGIUM; CHLORZOXAZONE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 CYP2E1; ENVIRONMENTAL MONITORING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PHENOTYPE; SPECTROMETRY, FLUORESCENCE; STYRENE;

EID: 0036765349     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00420-002-0334-4     Document Type: Article

References (27)

1. Carriére V, Berthou F, Baird S, Belloc C, Beaune P, De Waziers I (1996) Human cytochrome P450 2E1 (CYP2E1): From genotype to phenotype. Pharmacogenetics 6:203-211
2. Fritsche E, Pittman GS, Bell DA (2000) Localization, sequence analysis, and ethnic distribution of a 96-bp insertion in the promoter of the human CYP2E1 gene. Mutat Res Genomics 432:1-5
3. Frye RF, Adedoyin A, Mauro K, Matzke GR, Branch RA (1998) Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: Choice of dose and phenotypic trait measure. J Clin Pharmacol 38:82-89
4. Ghittori S, Maestri L, Imbriani M, Capodaglio E, Cavalleri A (1997) Urinary excretion of specific mercapturic acids in workers exposed to styrene. Am J Ind Med 31:636-644
5. Girre C, Lucas D, Hispard E, Menez C, Dally S, Menez J-F (1994) Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem Pharmacol 47:1503-1508
6. Guengerich FP, Kim DH, Iwasaki M (1991) Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suscepts. Chem Res Toxicol 4:168-179
7. Haufroid V, Gardinal S, Licot Villalpando M-L, Van Obbergh L, Clippe A, Lison D (2000) Biological monitoring of exposure to sevoflurane in operating room personnel by the measurement of hexafluoroisopropanol and fluoride in urine. Biomarkers 5:141-151
8. Haufroid V, Buchet J-P, Gardinal S, Ghittori S, Imbriani M, Hirvonen A, Lison D (2001) Importance of genetic polymorphisms of drug-metabolizing enzymes for the interpretation of biomarkers of exposure to styrene. Biomarkers 6:236-249
9. Hayashi S-I, Watanabe J, Kawajiri K (1991) Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 110:559-565
10. Kim H, Wang RS, Elovaara E, Raunio H, Pelkonen O, Aoyama T, Vainio H, Nakajima T (1997) Cytochrome P450 isozymes responsible for the metabolism of tuluene and styrene in human liver microsomes. Xenobiotica 27:657-665
11. Kim RB, O'Shea D, Wilkinson GR (1995) Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin Pharmacol Ther 57:645-655
12. Le Marchand L, Wilkinson GR, Wilkens LR (1999) Genetic and dietary predictors of CYP2E1 activity: A phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol Biomarkers Prev 3:515-516
13. Lieber CS (1997) Cytochrome P-4502E1: Its physiological and pathological role. Physiol Rev 77:517-544
14. Lucas D, Berthou F, Girre C, Poitrenaud F, Menez J-F (1993) High-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: A tool for indirect evaluation of cytochrome P4502E1 activity in humans. J Chromatogr B Biomed Sci Appl 622:79-86
15. Lucas D, Menez C, Girre C, Berthou F, Bodenez P, Joannet I, Hispard E, Bardou LG, Menez J-F (1995) Cytochrome P4502E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics 5:298-304
16. Lucas D, Ferrara R, Gonzalez E, Bodenez P, Albores A, Manno M, Berthou F (1999) Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans. Pharmacogenetics 9:377-388
17. McCarver DG, Byun R, Hines RN, Hichme M, Wegenek W (1998) A genetic polymorphism in the regulatory sequences of human CYP2E1: Association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol Appl Pharmacol 152:276-281
18. Nakajima T, Elovaara E, Gonzalez FJ, Gelboin HV, Vainio H, Aoyama T (1993) Characterization of the human cytochrome P450 isozymes responsible for styrene metabolism. IARC Sci Publ 127:101-108
19. Nomiyama T, Haufroid V, Buchet J-P, Miyauchi H, Tanaka S, Yamauchi T, Imamiya S, Seki Y, Omae K, Lison D (2001) Insertion polymorphism of CYP2E1 and urinary N-methylformamide after N,N-dimethylformamide exposure in Japanese workers. Int Arch Occup Environ Health 74:519-522
20. Persson I, Johansson I, Bergling H, Dahl ML, Seidegard J, Rylander R, Rannug A, Hogberg J, Ingelman Sundberg M (1993) Genetic polymorphism of cytochrome P4502E1 in a Swedish population: Relationship to incidence of lung cancer. FEBS Lett 319:207-211
21. Peter R, Bocker R, Beaune PH, Iwasaki M, Guengerich FP, Yang CS (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol 3:566-573
22. Powell H, Kitteringham NR, Pirmohamed M, Smith DA, Park BK (1998) Expression of cytochrome P4502E1 in human liver: Assessment by mRNA, genotype and phenotype. Pharmacogenetics 8:411-421
23. Rannug A, Alexandrie A-K, Persson I, Ingelman Sundberg M (1995) Genetic polymorphism of cytochromes P450 1A1, 2D6 and 2E1: Regulation and toxicological significance. J Occup Environ Med 37:25-36
24. Streetman DS, Bertino JS Jr, Nafziger AN (2000) Phenotyping of drug-metabolizing enzymes in adults: A review of in vivo cytochrome P450 phenotyping probes. Pharmacogenetics 10:187-216
25. Tanaka E, Terada M, Misawa S (2000) Cytochrome P450 2E1: Its clinical and toxicological role. J Clin Pharm Ther 25:165-175
26. Van Roosmalen PB, Drummond I (1978) Simultaneous determination by gas chromatography of the major metabolites in urine of toluene, xylenes and styrene. Br J Ind Med 35:56-60
27. Watanabe J, Hayashi S-I, Kawajiri K (1994) Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. J Biochem 116:321-326